[ET Net News Agency, 29 April 2024] REMEGEN (09995) fell 9.8% to HK$27.5, dipping below
the 100-D SMA of HK$27.952.
It hits an intra-day low of HK$27.35, and an intra-day high of HK$31.25. The total
shares traded was 2.21 million, with a value of HK$64.24m. The active buy/sell ratio is
37:63, with net selling turnover of HK$16.1m. CHINA INV INFO accounts for greatest net
responsive buying turnover of HK$7.49m, with volume weighted average price of HK$28.707.
MERRILL LYNCH FE accounts for greatest net responsive selling turnover of HK$3.16m, with
volume weighted average price of HK$28.945.
Basic Information
=================
---------------------------------
Nominal 27.500 % Chg -9.84%
High 31.250 Low 27.350
Shares Tr 2.21m Turnover 64.24m
10-D SMA 28.510 %H.V 64.906
20-D SMA 29.178 VWAP 29.048
50-D SMA 25.954 RSI14 47.417
---------------------------------
Status: Dipping below the 100-D SMA, active buy/sell ratio is 37:63, with net selling
turnover of HK$16.1m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
REMEGEN (09995) 27.50 -9.84
HUTCHMED (00013) 30.90 +1.81
GENSCRIPT BIO (01548) 11.96 +8.53
INNOVENT BIO (01801) 40.00 +2.17
EVEREST MED-B (01952) 24.25 -1.62
WUXI BIO (02269) 14.16 +5.04
TIGERMED (03347) 34.85 +3.72
BEIGENE (06160) 94.45 +2.72
SCICLONE PHARMA (06600) 17.98 -0.11
AKESO (09926) 48.90 +0.41
-----------------------------------------------
(ed)